Exact Mass: 477.08265400000005

Exact Mass Matches: 477.08265400000005

Found 81 metabolites which its exact mass value is equals to given mass value 477.08265400000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

8-methylthiooctyl glucosinolate

8-Methylthio-octyl glucosinolate

C16H31NO9S3 (477.1160876)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

CDP-glycerol

[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](2,3-dihydroxypropoxy)phosphinic acid

C12H21N3O13P2 (477.0549596)

Cdp-glycerol is a member of the class of compounds known as cdp-glycerols. Cdp-glycerols are glycerolipids with a cytidine diphosphate attached to the oxygen O1 or O2 of the glycerol part. Cdp-glycerol is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Cdp-glycerol can be found in a number of food items such as pummelo, elderberry, mugwort, and american butterfish, which makes cdp-glycerol a potential biomarker for the consumption of these food products. Cdp-glycerol is part of the Purine metabolism, and Glycerophospholipid metabolism pathways. It is a substrate for: Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase.

cefotaxime sodium

C16H16N5NaO7S2 (477.0388826)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate

(3,5-Dichlorophenyl)methyl 4-[3-oxo-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylic acid

C22H21Cl2N3O5 (477.08581960000004)

ARN-509

4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulphanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzene-1-carboximidic acid

C21H15F4N5O2S (477.0882538)

Benoxaprofen glucuronide

6-({2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoyl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20ClNO9 (477.08265400000005)

Suriclone

6-(7-Chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5H-(1,4)dithiino(2,3-c)pyrrol-5-yl-4-methylpiperazine-1-carboxylate

C20H20ClN5O3S2 (477.0696040000001)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Isorhamnetin 7-alpha-D-Glucosamine

7- [ (2-Amino-2-deoxy-alpha-D-glucopyranosyl) oxy ] -3,5-dihydroxy-2- (4-hydroxy-3-methoxyphenyl) -4H-1-benzopyran-4-one

C22H23NO11 (477.1271048)

Annotation level-3

Dermatan

C14H23NO15S (477.07883680000003)

Fmoc-Sar-Opfp

C24H16F5NO4 (477.0999436)

4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecan-1-amine

C11H8F17N (477.0385252)

Fmoc-Ala-OPfp

C24H16F5NO4 (477.0999436)

Acridine mustard

6-CHLORO-9-[3-N-(2-CHLOROETHYL)ETHYLAMINO]PROPYLAMINO-2-METHOXYACRIDINE DIHYDROCHLORIDE

C21H27Cl4N3O (477.09081320000007)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

GW843682X

5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide

C22H18F3N3O4S (477.09700640000005)

(2-Nitrobenzyl)(triphenyl)phosphonium bromide

C25H21BrNO2P (477.04931960000005)

2-Thiophenecarboxamide, 5-chloro-N-[2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)-3-(trifluoromethyl)phenyl]amino]propyl]

C19H19ClF3N3O4S (477.07368400000007)

Flutropium bromide

C24H29BrFNO3 (477.13147160000005)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer

1,3,4,6-TETRA-O-ACETYL-2-DEOXY-2-PHTHALIMIDO-BETA-D-GLUCOPYRANOSE

C22H23NO11 (477.1271048)

Fmoc-Phe(F5)-OH

C24H16F5NO4 (477.0999436)

(4-Nitrobenzyl)(triphenyl)phosphonium bromide

C25H21BrNO2P (477.04931960000005)

ARN-509

Apalutamide

C21H15F4N5O2S (477.0882538)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen

Fmoc-D-Ala-OPfp

C24H16F5NO4 (477.0999436)

VR23

C19H16ClN5O6S (477.05097860000006)

Basic Blue 162

C20H23N5O5S2 (477.1140548)

empts

C15H17HgNO2S (477.06862620000004)

Fmoc-D-Phe(F5)-OH

C24H16F5NO4 (477.0999436)

1-((2-Bromophenyl)sulfonyl)-5-methoxy-3-((4-methylpiperazin-1-yl)methyl)-1H-indole

C21H24BrN3O3S (477.0721654)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

Sulopenem etzadroxil

C19H27NO7S3 (477.0949592)

C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

N-[[3-[(3-chlorophenyl)sulfamoyl]-4-methylanilino]-sulfanylidenemethyl]-4-fluorobenzamide

C21H17ClFN3O3S2 (477.0383854)

GlcA(b1-3)GalNAc4S

C14H23NO15S (477.07883680000003)

Pantoyl adenylate

C16H24N5O10P (477.12607340000005)

[Cytidine-5-phosphate] glycerylphosphoric acid ester

C12H21N3O13P2 (477.0549596)

hydrogen peroxide;iron;2,3,4,5,6-pentahydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptanoate

C13H25FeO15- (477.05427900000007)

Dermatan sulfate

C14H23NO15S (477.07883680000003)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants

Chondroitin 4-sulfate

C14H23NO15S (477.07883680000003)

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H23NO15S (477.07883680000003)

AUREOMYCIN

C22H22ClN2O8- (477.1064622)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

1-Methoxy-3-indolylmethyl-glucosinolate

C17H21N2O10S2- (477.06375859999997)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-9-methylsulfanyl-N-sulfooxynonanimidothioate

C16H31NO9S3 (477.1160876)

[(E)-[2-(4-methoxy-1H-indol-3-yl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate

C17H21N2O10S2- (477.06375859999997)

(2R)-CDP-glycerol

C12H21N3O13P2 (477.0549596)

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 1,3-dihydroxypropan-2-yl hydrogen phosphate

C12H21N3O13P2 (477.0549596)

Neoglucobrassicin anion

C17H21N2O10S2- (477.06375859999997)

N-(5-methyl-3-isoxazolyl)-2-[[1-[[3-(trifluoromethyl)phenyl]methyl]-3-indolyl]sulfonyl]acetamide

C22H18F3N3O4S (477.09700640000005)

alpha-D-GlcNAc6S-(1->4)-D-GlcA

C14H23NO15S (477.07883680000003)

A carbohydrate acid derivative that consists of D-glucuronic acid having a 6-O-sulfo-N-acetyl-alpha-D-glucosaminyl residue attached at position 4. An intermediate glycan in the degradation of heparan sulfate.